ANDA Submissions Drop To Start FY 2021, Perhaps Forced Down By COVID-19

 
• By Derrick Gingery
  
Bottle of generic drugs
FDA ANDA approvals were ahead of their FY 2020 pace in the first quarter of FY 2021. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics